Home
Conditions
Peripheral T-cell Lymphoma

Clinical trial condition

Peripheral T-cell Lymphoma

Explore clinical trials studying Peripheral T-cell Lymphoma. Study availability and eligibility vary by location and protocol.

100 public trials 16 recruiting studies

Refine in advanced search Browse all conditions

Peripheral T-cell Lymphoma trial results

Recruiting

Bendamustine Combined With Chidamide and Lenalidomide for Relapsed and Refractory PTCL Patients

NCT07072221

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Recruiting

Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.

NCT03964480

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Stanford University Stanford, California, United States

IRCCS Istituto Tumori "Giovanni Paolo II" Bari, Italy

Palermo_La Maddalena Palermo, Italy

Terni-Santa Maria Terni, Italy

View Trial Details

Recruiting

A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies

NCT06914037

Conditions: Cutaneous T-cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Golidocitinib Plus CHOP in Newly Diagnosed PTCL

NCT06739265

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Peking Union Medical College Hospital Beijing, China

View Trial Details

Recruiting

Linperlisib in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma

NCT05949944

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma

NCT04922567

Conditions: CHOP, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Enrolling by Invitation

BrEto-TCL - Defining the Role of Brentuximab and Etoposide for Optimizing First-line Therapy of T-cell Lymphomas

NCT07258680

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System

NCT06385522

Conditions: Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Chidamide Plus Golidocitinib in Relapsed/Refractory Peripheral T-Cell Lymphoma

NCT06757387

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Completed

Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

NCT02232516

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +32 more
Locations: City of Hope Duarte, California, United States

Yale University New Haven, Connecticut, United States

Northwestern University Chicago, Illinois, United States

Weill Cornell Medicine New York, United States

View Trial Details

Peripheral T-cell Lymphoma

Peripheral T-cell Lymphoma trial results

Related conditions